Literature DB >> 32808252

Current Perspectives on Aerobic Exercise in People with Parkinson's Disease.

Sabine Schootemeijer1, Nicolien M van der Kolk1, Bastiaan R Bloem2, Nienke M de Vries1.   

Abstract

Parkinson's disease (PD) is a progressive neurological disorder characterized by motor and non-motor symptoms for which only symptomatic treatments exist. Exercise is a widely studied complementary treatment option. Aerobic exercise, defined as continuous movement of the body's large muscles in a rhythmic manner for a sustained period that increases caloric requirements and aims at maintaining or improving physical fitness, appears promising. We performed both a scoping review and a systematic review on the generic and disease-specific health benefits of aerobic exercise for people with PD. We support this by a meta-analysis on the effects on physical fitness (VO2max), motor symptoms (Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) motor section), and health-related quality of life (39-item Parkinson's disease Questionnaire (PDQ-39)). Aerobic exercise has generic health benefits for people with PD, including a reduced incidence of cardiovascular disease, a lower mortality, and an improved bone health. Additionally, there is level 1 evidence that aerobic exercise improves physical fitness (VO2max) and attenuates motor symptoms (MDS-UPDRS motor section) in the off-medication state, although the long-term effects (beyond 6 months) remain unclear. Dosing the exercise matters: improvements appear to be greater after training at higher intensities compared with moderate intensities. We found insufficient evidence for a beneficial effect of aerobic exercise on health-related quality of life (PDQ-39) and conflicting results regarding non-motor symptoms. Compliance to exercise regimes is challenging for PD patients but may be improved by adding exergaming elements to the training program. Aerobic exercise seems a safe intervention for people with PD, although care must be taken to avoid falls in at-risk individuals. Further studies are needed to establish the long term of aerobic exercise, including a focus on non-motor symptoms and health-related quality of life.

Entities:  

Keywords:  Exercise; Parkinson’s disease; endurance training; health-related quality of life; locomotion; mobility limitation

Mesh:

Year:  2020        PMID: 32808252      PMCID: PMC7851311          DOI: 10.1007/s13311-020-00904-8

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  78 in total

1.  Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.

Authors:  J E Ahlskog; M D Muenter
Journal:  Mov Disord       Date:  2001-05       Impact factor: 10.338

2.  The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease.

Authors:  Beth E Fisher; Allan D Wu; George J Salem; Jooeun Song; Chien-Ho Janice Lin; Jeanine Yip; Steven Cen; James Gordon; Michael Jakowec; Giselle Petzinger
Journal:  Arch Phys Med Rehabil       Date:  2008-06-13       Impact factor: 3.966

3.  Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease.

Authors:  Barbara Steiner; Christine Winter; Kai Hosman; Eberhard Siebert; Gerd Kempermann; Dominique S Petrus; Andreas Kupsch
Journal:  Exp Neurol       Date:  2005-12-19       Impact factor: 5.330

4.  The Parkinson Pandemic-A Call to Action.

Authors:  E Ray Dorsey; Bastiaan R Bloem
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

5.  Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson's disease.

Authors:  Márcio Ferreira Dutra; Mariane Jaeger; Jocemar Ilha; Pedro Ivo Kalil-Gaspar; Simone Marcuzzo; Matilde Achaval
Journal:  Neurol Sci       Date:  2012-01-10       Impact factor: 3.307

Review 6.  Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues.

Authors:  Jeff M Bronstein; Michele Tagliati; Ron L Alterman; Andres M Lozano; Jens Volkmann; Alessandro Stefani; Fay B Horak; Michael S Okun; Kelly D Foote; Paul Krack; Rajesh Pahwa; Jaimie M Henderson; Marwan I Hariz; Roy A Bakay; Ali Rezai; William J Marks; Elena Moro; Jerrold L Vitek; Frances M Weaver; Robert E Gross; Mahlon R DeLong
Journal:  Arch Neurol       Date:  2010-10-11

7.  Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson's disease.

Authors:  Beth E Fisher; Quanzheng Li; Angelo Nacca; George J Salem; Jooeun Song; Jeanine Yip; Jennifer S Hui; Michael W Jakowec; Giselle M Petzinger
Journal:  Neuroreport       Date:  2013-07-10       Impact factor: 1.837

8.  Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

Authors:  Giselle M Petzinger; John P Walsh; Garnik Akopian; Elizabeth Hogg; Avery Abernathy; Pablo Arevalo; Patty Turnquist; Marta Vucković; Beth E Fisher; Daniel M Togasaki; Michael W Jakowec
Journal:  J Neurosci       Date:  2007-05-16       Impact factor: 6.167

9.  Exercise in an animal model of Parkinson's disease: Motor recovery but not restoration of the nigrostriatal pathway.

Authors:  M J Churchill; L Pflibsen; M D Sconce; C Moore; K Kim; C K Meshul
Journal:  Neuroscience       Date:  2017-07-25       Impact factor: 3.590

10.  The Physical Activity Guidelines for Americans.

Authors:  Katrina L Piercy; Richard P Troiano; Rachel M Ballard; Susan A Carlson; Janet E Fulton; Deborah A Galuska; Stephanie M George; Richard D Olson
Journal:  JAMA       Date:  2018-11-20       Impact factor: 157.335

View more
  8 in total

1.  Vitamin D (VD3) Intensifies the Effects of Exercise and Prevents Alterations of Behavior, Brain Oxidative Stress, and Neuroinflammation, in Hemiparkinsonian Rats.

Authors:  Roberta Oliveira da Costa; Carlos Vinicius Jataí Gadelha-Filho; Pedro Everson Alexandre de Aquino; Ludmila Araújo Rodrigues Lima; Jalles Dantas de Lucena; Wesley Lyeverton Correia Ribeiro; Francisco Arnaldo Viana Lima; Kelly Rose Tavares Neves; Glauce Socorro de Barros Viana
Journal:  Neurochem Res       Date:  2022-08-26       Impact factor: 4.414

2.  Is Being Physically Active Enough or Do People with Parkinson's Disease Need Structured Supervised Exercise? Lessons Learned from COVID-19.

Authors:  Josefa Domingos; Carlos Família; Júlio Belo Fernandes; John Dean; Catarina Godinho
Journal:  Int J Environ Res Public Health       Date:  2022-02-19       Impact factor: 3.390

3.  The Category of Conventional Physiotherapy: The Case of Parkinson's Disease Guidelines.

Authors:  Martina Hoskovcová; Evžen Růžička; Ota Gál
Journal:  J Pers Med       Date:  2022-04-30

Review 4.  Motor Dysfunction in REM Sleep Behavior Disorder: A Rehabilitation Framework for Prodromal Synucleinopathy.

Authors:  Rebekah L S Summers; Miriam R Rafferty; Michael J Howell; Colum D MacKinnon
Journal:  Neurorehabil Neural Repair       Date:  2021-05-12       Impact factor: 3.919

5.  Effects of Endurance Training on Motor Signs of Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Filipe Oliveira de Almeida; Vagner Santana; Daniel M Corcos; Carlos Ugrinowitsch; Carla Silva-Batista
Journal:  Sports Med       Date:  2022-02-03       Impact factor: 11.928

6.  The silver linings of Parkinson's disease.

Authors:  Araceli Alonso-Canovas; Jos Voeten; Omotola Thomas; Larry Gifford; Jon A Stamford; Bastiaan R Bloem
Journal:  NPJ Parkinsons Dis       Date:  2022-03-03

7.  Correction to: Current Perspectives on Aerobic Exercise in People with Parkinson's Disease.

Authors:  Sabine Schootemeijer; Nicolien M van der Kolk; Bastiaan R Bloem; Nienke M de Vries
Journal:  Neurotherapeutics       Date:  2022-03       Impact factor: 6.088

8.  Effectiveness of Long-Term Physiotherapy in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Yohei Okada; Hiroyuki Ohtsuka; Noriyuki Kamata; Satoshi Yamamoto; Makoto Sawada; Junji Nakamura; Masayuki Okamoto; Masaru Narita; Yasutaka Nikaido; Hideyuki Urakami; Tsubasa Kawasaki; Shu Morioka; Koji Shomoto; Nobutaka Hattori
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.